We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.76B
AUM Growth
-$525M
Cap. Flow
-$439M
Cap. Flow %
-15.9%
Top 10 Hldgs %
38.29%
Holding
343
New
69
Increased
54
Reduced
100
Closed
111

Top Buys

Rank Stock Value
1
VRAY
ViewRay, Inc.
VRAY
+$17.9M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$17.3M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$14.1M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$14M
5
CUTR
Cutera, Inc.
CUTR
+$12.7M

Top Sells

Rank Stock Value
1
SEER icon
Seer Inc
SEER
+$24.7M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.4M
3
LIVN icon
LivaNova
LIVN
+$20.2M
4
GKOS icon
Glaukos
GKOS
+$17.5M
5
COO icon
Cooper Companies
COO
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 29.75%
2 Consumer Staples 0.58%
3 Financials 0.5%
4 Consumer Discretionary 0.42%
5 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REUN
326
CALL
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
– –
-61,140
Closed -$1.4M
CSII
327
PUT
DELISTED
Cardiovascular Systems, Inc.
CSII
– –
-25,000
Closed -$821K
FRONU
328
DELISTED
Frontier Acquisition Corp. Units
FRONU
– –
-213,023
Closed -$2.1M
IVC
329
DELISTED
Invacare Corporation
IVC
– –
-1,137,028
Closed -$5.41M
TCDA
330
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-95,022
Closed -$441K
ABMD
331
PUT
DELISTED
Abiomed Inc
ABMD
– –
-30,000
Closed -$9.77M
PHAS
332
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-27,944
Closed -$87K
CCXI
333
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-40,600
Closed -$694K
CCXI
334
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-300,000
Closed -$5.13M
OCDX
335
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
– –
-550,000
Closed -$10.2M
APR
336
DELISTED
Apria, Inc. Common Stock
APR
– –
-355,465
Closed -$13.2M
INOV
337
CALL
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
– –
-1,328,700
Closed -$53.5M
XLRN
338
CALL
DELISTED
Acceleron Pharma
XLRN
– –
-64,400
Closed -$11.1M
KDMN
339
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-52,300
Closed -$456K
MSON
340
DELISTED
Misonix Inc
MSON
– –
-218,100
Closed -$5.52M
MAACW
341
DELISTED
Montes Archimedes Acquisition Corp. Warrant
MAACW
– –
-205,400
Closed -$306K
10 11 12 13
14

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Pura Vida Investments held 343 positions worth $2.76B, down 16% from $3.29B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $439M in Q4 2021, closing 111 positions and reducing 100 holdings. Its most notable exit was Seer Inc, an estimated $24.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Pura Vida Investments opened a new position in BioMarin Pharmaceuticals worth $15M.

  • Pura Vida Investments's largest Q4 2021 buy was BioMarin Pharmaceuticals: 170,210 shares worth $15M.
  • Pura Vida Investments added most to ViewRay, Inc. in Q4 2021, an estimated $17.9M increase.
  • Pura Vida Investments's biggest Q4 2021 reduction was LivaNova, cutting an estimated $20.2M.
  • Pura Vida Investments fully exited Seer Inc in Q4 2021, selling an estimated $24.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $2.76B portfolio in Q4 2021.
  • Pura Vida Investments opened 69 new positions and closed 111 in Q4 2021.
  • Pura Vida Investments's portfolio value fell 16% quarter-over-quarter to $2.76B.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.